Cargando…
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
Inflammatory breast cancer (IBC) is a virulent form of breast cancer, and novel treatment strategies are urgently needed. Immunohistochemical analysis of tumors from women with a clinical diagnosis of IBC (n = 147) and those with non-IBC breast cancer (n = 2510) revealed that, whereas in non-IBC cas...
Autores principales: | Alexander, Angela, Karakas, Cansu, Chen, Xian, Carey, Jason P.W ., Yi, Min, Bondy, Melissa, Thompson, Patricia, Cheung, Kwok Leung, Ellis, Ian O., Gong, Yun, Krishnamurthy, Savitri, Alvarez, Ricardo H., Ueno, Naoto T., Hunt, Kelly K., Keyomarsi, Khandan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362453/ https://www.ncbi.nlm.nih.gov/pubmed/28107181 http://dx.doi.org/10.18632/oncotarget.14689 |
Ejemplares similares
-
PKC iota promotes ovarian tumor progression through deregulation of cyclin E
por: Nanos-Webb, Angela, et al.
Publicado: (2015) -
Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age
por: Johnston, Simon J., et al.
Publicado: (2020) -
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
por: Caruso, Joseph A, et al.
Publicado: (2014) -
Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
por: Caruso, Joseph A, et al.
Publicado: (2015) -
Leveraging MYC as a therapeutic treatment option for TNBC
por: Carey, Jason P.W., et al.
Publicado: (2018)